Nevertheless, in our in vivo experiments, the expression of CXCR4 in tumor tissues, as well as the expression of SDF-1α in the tissues adjacent to the HCC ones, was increased following FK506 treatment. The gene discussed is CXCL12; the disease is hepatocellular carcinoma.